U.S. labor market strengthening, factories struggling
WASHINGTON (Reuters) – The number of Americans filing for unemployment benefits last week fell from a five-month high, suggesting sustained labor market healing that could lead to further Federal Reserve interest rate hikes next year.
Volkswagen chief appoints new top management team
FRANKFURT (Reuters) – Volkswagen’s chief executive Matthias Mueller named his new management team on Thursday, including the replacement for the group’s research and development chief who left earlier this month as a result of the diesel emissions scan…
General Mills sales miss estimates on weak U.S. demand, strong dollar
(Reuters) – General Mills Inc reported a bigger-than-expected drop in quarterly sales, hurt by a strong dollar and weak demand for its snacks and baking products in the United States, and cut its full-year sales forecast.
Confident and clear, Yellen says rate path will be well signaled
SAN FRANCISCO (Reuters) – The unanimous backing Federal Reserve Chair Janet Yellen got for the Fed’s first rate hike since the financial crisis let her deliver a clear message: Don’t expect further rate hikes for a while, and when we are ready, we’ll t…
Navistar posts loss, says goal is profitability in 2016
CHICAGO (Reuters) – Truckmaker Navistar International Corp posted its 13th consecutive quarterly loss on Thursday amid declining revenue but said that it plans to further cut costs in 2016 and return to profitability.
Asia policymakers spared Fed jolt, look to support shaky economies
JAKARTA (Reuters) – Asian policymakers on Thursday applauded a historic turn in U.S. monetary policy, but analysts warned the region’s economies face vulnerabilities, with Taiwan cutting interest rates, although markets took the Federal Reserve rate hi…
Lufthansa plays down report about new chairman
FRANKFURT (Reuters) – German airline Lufthansa played down a report that it could get a new chairman after Merck KGaA Chief Executive Karl-Ludwig Kley was quoted as saying he would take the job if it was offered to him.
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
LONDON (Reuters) – AstraZeneca is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at the cost of a near-term hit to earnings.
Russia says IMF’s decision on Ukraine debt changes nothing
BEIJING (Reuters) – The International Monetary Fund’s decision on Ukraine’s debt to Russia did not change anything to Moscow, Russian Deputy Finance Minister Sergei Storchak told reporters in Beijing on Thursday.
Australian tax office names names in multinational avoidance row
SYDNEY (Reuters) – Australian tax authorities on Thursday took the unprecedented step of publishing the records of hundreds of companies, including Google Inc and Apple Inc , which show they paid little or no tax on their in-country earnings.
